Stephen P. Eisenberg

6.3k total citations · 2 hit papers
42 papers, 5.4k citations indexed

About

Stephen P. Eisenberg is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Stephen P. Eisenberg has authored 42 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Immunology and 10 papers in Genetics. Recurrent topics in Stephen P. Eisenberg's work include Immune Response and Inflammation (16 papers), RNA and protein synthesis mechanisms (9 papers) and Virus-based gene therapy research (5 papers). Stephen P. Eisenberg is often cited by papers focused on Immune Response and Inflammation (16 papers), RNA and protein synthesis mechanisms (9 papers) and Virus-based gene therapy research (5 papers). Stephen P. Eisenberg collaborates with scholars based in United States, South Africa and Switzerland. Stephen P. Eisenberg's co-authors include William P. Arend, Robert C. Thompson, David J. Dripps, Charles Hannum, Evie L. Verderber, Richard Thompson, Michael Brewer, R J Evans, Barbara J. Brandhuber and Howard G. Welgus and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Stephen P. Eisenberg

42 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

1990 949 citations Charles Hannum, Carol Wilcox et al. Nature profile →
Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

1990 918 citations Stephen P. Eisenberg, R J Evans et al. Nature profile →

Peers

Countries citing papers authored by Stephen P. Eisenberg

Since Specialization

Citations

This map shows the geographic impact of Stephen P. Eisenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen P. Eisenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen P. Eisenberg more than expected).

Fields of papers citing papers by Stephen P. Eisenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen P. Eisenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen P. Eisenberg. The network helps show where Stephen P. Eisenberg may publish in the future.

Co-authorship network of co-authors of Stephen P. Eisenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen P. Eisenberg. A scholar is included among the top collaborators of Stephen P. Eisenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen P. Eisenberg. Stephen P. Eisenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PEGylation Improves the Pharmacokinetic Properties and Ability of Interferon Gamma to Inhibit Growth of a Human Tumor Xenograft in Athymic Mice 2014 ·Journal of Interferon & Cytokine Research ·(unknown), Stephen P. Eisenberg, Sharon J. Carlson, Elizabeth A. Chlipala, George N. Cox, Mary S. Rosendahl	16
2	Site-Specific PEGylation Enhances the Pharmacokinetic Properties and Antitumor Activity of Interferon Beta-1b 2013 ·Journal of Interferon & Cytokine Research ·(unknown), Stephen P. Eisenberg, Mary S. Rosendahl, Elizabeth A. Chlipala, (unknown), Daniel H. Doherty, George N. Cox	11
3	Recombinant murine growth hormone from E. coli inclusion bodies: Expression, high‐pressure solubilization and refolding, and characterization of activity and structure 2010 ·Biotechnology Progress ·(unknown), (unknown), Stephen P. Eisenberg, Mary S. Rosendahl, Theodore W. Randolph	17
4	Design of homogeneous, monopegylated erythropoietin analogs with preserved in vitro bioactivity 2006 ·Experimental Hematology ·(unknown), Daniel H. Doherty, Stephen P. Eisenberg, Darin Smith, Mary S. Rosendahl, (unknown), Dean P. Edwards, Elizabeth A. Chlipala, George N. Cox	33
5	Regulation of an Endogenous Locus Using a Panel of Designed Zinc Finger Proteins Targeted to Accessible Chromatin Regions 2001 ·Journal of Biological Chemistry ·Peiqi Liu, Edward J. Rebar, Lei Zhang, Qiang Liu, Andrew C. Jamieson, Yuxin Liang, Hong Qi, (unknown), Bingliang Chen, Matthew Mendel, Xiaohong Zhong, Ya-Li Lee, Stephen P. Eisenberg, S. Kaye Spratt, Casey C. Case, Alan P. Wolffe	191
6	Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. 1995 ·Journal of Clinical Investigation ·Tessie McNeely, (unknown), David J. Dripps, J M Orenstein, Stephen P. Eisenberg, Sharon M. Wahl	363
7	Mapping Receptor Binding Sites in Interleukin (IL)-1 Receptor Antagonist and IL-1β by Site-directed Mutagenesis 1995 ·Journal of Biological Chemistry ·R J Evans, (unknown), John D. Childs, Guy Vigers, Barbara J. Brandhuber, Jack J. Skalicky, Robert C. Thompson, Stephen P. Eisenberg	83
8	Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. 1994 ·Journal of Clinical Investigation ·M. Ferretti, Vincenzo Casini–Raggi, Theresa T. Pizarro, Stephen P. Eisenberg, Cynthia C. Nast, Fabio Cominelli	134
9	Differential Regulation of Group A Streptococcal Peptidoglycan- Polysaccharide (PG-APS)-Stimulated Macrophage Production of IL-1 by Rat Strains Susceptible and Resistant to PG-APS-Induced Arthritis 1993 ·Cellular Immunology ·Lynn A. Bristol, Scott K. Durum, Stephen P. Eisenberg	14
10	Human IL-1 receptor antagonist promoter. Cell type-specific activity and identification of regulatory regions 1992 ·The Journal of Immunology ·Michael F. Smith, Denise M. Eidlen, Michael Brewer, Stephen P. Eisenberg, William P. Arend, A Gutierrez-Hartmann	39
11	Interleukin-1 receptor antagonist (IL-1ra) as a probe and as a treatment for IL-1 mediated disease 1992 ·International Journal of Immunopharmacology ·Robert C. Thompson, David J. Dripps, Stephen P. Eisenberg	28
12	IL-1ra ELISA: reduction and alkylation of synovial fluid eliminates interference by IgM rheumatoid factors 1991 ·Journal of Immunological Methods ·Mark Malyak, Fenneke G. Joslin, Evie L. Verderber, Stephen P. Eisenberg, William P. Arend	34
13	IL-1ra: properties and uses of an interleukin-1 receptor antagonist. 1991 ·PubMed ·Robert C. Thompson, David J. Dripps, Stephen P. Eisenberg	7
14	Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. 1990 ·Journal of Clinical Investigation ·William P. Arend, Howard G. Welgus, Reid C. Thompson, Stephen P. Eisenberg	471
15	Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor breakdown → 1990 ·Nature ·Charles Hannum, Carol Wilcox, William P. Arend, Fenneke G. Joslin, David J. Dripps, (unknown), Lyman G. Armes, Andreas Sommer, Stephen P. Eisenberg, Robert C. Thompson	949
16	Pharmacokinetics and Distribution of Recombinant Secretory Leukocyte Proteinase Inhibitor in Rats 1990 ·American Review of Respiratory Disease ·Alain Gast, Wayne H. Anderson, A. Probst, Hanspeter Nick, Reid C. Thompson, Stephen P. Eisenberg, Hans Peter Schnebli	21
17	Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist breakdown → 1990 ·Nature ·Stephen P. Eisenberg, R J Evans, William P. Arend, Evie L. Verderber, Michael Brewer, Charles Hannum, Robert C. Thompson	918
18	Promoter Domains Required for Expression of Plasmid-Borne Copies of the Herpes Simplex Virus Thymidine Kinase Gene in Virus-Infected Mouse Fibroblasts and Microinjected Frog Oocytes 1985 ·Molecular and Cellular Biology ·Stephen P. Eisenberg, Donald M. Coen, (unknown)	51
19	Alternate Utilization of Two Regulatory Domains Within the Moloney Murine Sarcoma Virus Long Terminal Repeat 1985 ·Molecular and Cellular Biology ·Barbara J. Graves, Stephen P. Eisenberg, Donald M. Coen, Steven L. McKnight	9
20	Role of tRNA Trp and Leader RNA: Secondary Structure in Attenuation of the trp Operon 1980 ·Cold Spring Harbor Monograph Archive ·Stephen P. Eisenberg, Larry Soll, Michael Yarus	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact